-
801
-
802
-
803
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Published 2023-07-01Get full text
Article -
804
-
805
The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature
Published 2020-08-01“…Despite advances in surgical and medical neuro-oncology, the median survival is about 15 months. …”
Get full text
Article -
806
Clustering Functional Magnetic Resonance Imaging Time Series in Glioblastoma Characterization: A Review of the Evolution, Applications, and Potentials
Published 2024-03-01“…This article emphasizes the importance of incorporating cutting-edge data analysis techniques into neuroimaging and neuro-oncology research. By providing a detailed perspective, this approach may guide future investigations and boost the development of tailored therapeutic strategies for GBM.…”
Get full text
Article -
807
-
808
Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology
Published 2023-06-01Get full text
Article -
809
Extranodal lymphoma: pathogenesis, diagnosis and treatment
Published 2023-09-01Get full text
Article -
810
A Multi-Disciplinary Approach to Diagnosis and Treatment of Radionecrosis in Malignant Gliomas and Cerebral Metastases
Published 2022-12-01“…Additionally, we provide the experience of a tertiary tumor center with this important issue in neuro-oncology and provide an institutional pathway dealing with this problem.…”
Get full text
Article -
811
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival
Published 2021-06-01Get full text
Article -
812
Clinical Decision Support Systems for Brain Tumour Diagnosis and Prognosis: A Systematic Review
Published 2023-07-01“…This review also examines various CDSS tool types, system features, techniques, accuracy, and outcomes, to provide the latest evidence available in the field of neuro-oncology. An overview of such CDSSs used to support clinical decision-making in the management and treatment of brain tumours, along with their benefits, challenges, and future perspectives has been provided. …”
Get full text
Article -
813
Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.
Published 2022-01-01“…<h4>Results</h4>Out of 25 patients, 11 (44%) were classified with pseudoprogression and 14 (56%) with true progression based on the Response Assessement in Neuro-Oncology criteria. rCBVmax was lower for pseudoprogression (3.4 vs. 7.6; p = 0.033) on early follow-up MRI. …”
Get full text
Article -
814
Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials
Published 2022-11-01“…Indeed, for several proteins (i.e., HSP10, HSPB1, DNAJC10, HSPA7, HSP90), a direct correlation between the protein level expression and poor overall survival prognosis for patients was demonstrated that provides a possibility to employ them as prognostic markers in neuro-oncology. Although small molecular inhibitors for HSPs, particularly for HSP27, HSP70, and HSP90 families, were studied in various solid and hematological malignancies demonstrating therapeutic potential, still their potential was not yet fully explored in CNS tumors. …”
Get full text
Article -
815
-
816
-
817
PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model
Published 2024-02-01Get full text
Article -
818
Cell-Population Dynamics in Diffuse Gliomas during Gliomagenesis and Its Impact on Patient Survival
Published 2022-12-01“…Diffuse gliomas continue to be an important problem in neuro-oncology. To solve it, studies have considered the issues of molecular pathogenesis from the intratumoral heterogeneity point. …”
Get full text
Article -
819
In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography
Published 2022-06-01Get full text
Article -
820